Baby Giants Investing

#41 - Nearmap's $1.1b Takeover Bid, rapid results roundup: Clinuvel Pharmaceuticals, Redbubble, Temple & Webster & 4DS Memory

August 18, 2022 BabyGiants Episode 41

Andrew, Matt and Kev chat through good news on the fusion front, patents and new technology, Thomas Bravo's $1.1b takeover offer for Nearmap (ASX: NEA), Results (Clinuvel Pharmaceuticals (ASX: CUV), Redbubble (ASX: RBL), and Temple & Webster Group (ASX: TPW)), the dangers of extrapolation, and 4DS Memory (ASX: 4DS).

Follow us on Twitter: @BabyGiantsPod

-----

1:00 - Good News - Fusion

3:16 - Patents/New Technology

4:45 - Nearmap (ASX: NEA) takeover offer from Thomas Bravo

16:15 - Clinuvel Pharmaceuticals (ASX: CUV)

28:11 - Redbubble (ASX: RBL)

36:57 - Temple & Webster Group (ASX: TPW)

42:40 - Dangers of extrapolation

46:09 - 4DS Memory (ASX: 4DS)

48:48 - New tech businesses